Emmanuel Ndashimye

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Nature communications

Viruses

FEMS microbiology reviews

PLoS pathogens

Center for AIDS research at Joint Clinical Research Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for AIDS research at Joint Clinical Research Center Apr 15 2011 - Sep 01 2016

Uganda

Head HIV drug resistance services :: Molecular Biology/infectious diseases

Publications

Hannah O Ajoge, Tyler M Renner, Kasandra Bélanger, Matthew Greig, Samar Dankar, Hinissan P Kohio, Macon D Coleman, Emmanuel Ndashimye, Eric J Arts, Marc-André Langlois, Stephen D Barr
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature communications 14 (1) (2023)
Hannah O Ajoge, Tyler M Renner, Kasandra Bélanger, Matthew Greig, Samar Dankar, Hinissan P Kohio, Macon D Coleman, Emmanuel Ndashimye, Eric J Arts, Marc-André Langlois, Stephen D Barr
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature communications 14 (1) (2023)
Hinissan P Kohio, Hannah O Ajoge, Macon D Coleman, Emmanuel Ndashimye, Richard M Gibson, Eric J Arts, Stephen D Barr
Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses. Viruses 15 (2) (2023)
Hinissan P Kohio, Hannah O Ajoge, Macon D Coleman, Emmanuel Ndashimye, Richard M Gibson, Eric J Arts, Stephen D Barr
Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses. Viruses 15 (2) (2023)
Hannah O Ajoge, Tyler M Renner, Kasandra Bélanger, Matthew Greig, Samar Dankar, Hinissan P Kohio, Macon D Coleman, Emmanuel Ndashimye, Eric J Arts, Marc-André Langlois, Stephen D Barr
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature communications 14 (1) (2023)
Hannah O Ajoge, Tyler M Renner, Kasandra Bélanger, Matthew Greig, Samar Dankar, Hinissan P Kohio, Macon D Coleman, Emmanuel Ndashimye, Eric J Arts, Marc-André Langlois, Stephen D Barr
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature communications 14 (1) (2023)
Emmanuel Ndashimye, Paul S Reyes, Eric J Arts
New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates? FEMS microbiology reviews (2022)
Emmanuel Ndashimye, Yue Li, Paul S Reyes, Mariano Avino, Abayomi S Olabode, Cissy M Kityo, Fred Kyeyune, Immaculate Nankya, Miguel E Quiñones-Mateu, Stephen D Barr, Eric J Arts
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations. The Journal of antimicrobial chemotherapy 76 (11) (2021)
Emmanuel Ndashimye, Eric J Arts
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030. Infectious diseases of poverty 8 (1) (2019)
Katja Klein, Gabrielle Nickel, Immaculate Nankya, Fred Kyeyune, Korey Demers, Emmanuel Ndashimye, Cynthia Kwok, Pai-Lien Chen, Sandra Rwambuya, Art F Y Poon, Marshall Munjoma, Tsungai Chipato, Josaphat Byamugisha, Peter Mugyenyi, Robert A Salata, Charles S Morrison, Eric J Arts
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection. PLoS pathogens 14 (1) (2018)

Emmanuel Ndashimye.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emmanuel Ndashimye